PCM
CORZ icon

Prelude Capital Management’s Core Scientific CORZ Stock Holding History

Prelude Capital Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-49,524
Closed -$741K – 1282
2026
Q1 		$741K Sell
49,524
-301,632
-86% -$5.14M 0.06% 371
2025
Q4 		$5.11M Buy
351,156
+258,287
+278% +$4.5M 0.38% 41
2025
Q3 		$1.67M Sell
92,869
-311,966
-77% -$4.58M 0.13% 203
2025
Q2 		$6.91M Sell
404,835
-635,191
-61% -$6.36M 0.67% 21
2025
Q1 		$7.53M Buy
1,040,026
+139,215
+15% +$1.58M 0.57% 25
2024
Q4 		$12.7M Buy
900,811
+336,014
+59% +$4.96M 0.79% 12
2024
Q3 		$6.7M Buy
+564,797
New +$5.85M 0.41% 35

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Prelude Capital Management's CORZ Position: Q2 2026 in Review

Prelude Capital Management sold out of Core Scientific (CORZ) in Q2 2026, closing a stake of 49,524 shares — an estimated $741K sold.

Prelude Capital Management first reported a position in CORZ in Q3 2024 and held it in 7 quarters. The position peaked at $12.7M in Q4 2024. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Prelude Capital Management reported no remaining Core Scientific position as of Q2 2026 after selling out during the quarter.
  • Prelude Capital Management sold 49,524 Core Scientific shares in Q2 2026, an estimated $741K.
  • Prelude Capital Management first reported a position in Core Scientific in Q3 2024 and held it in 7 quarters.
  • Prelude Capital Management's Core Scientific position peaked at $12.7M in Q4 2024.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.